Understanding MK2866 Driada Medical
MK2866 Driada Medical is a selective androgen receptor modulator manufactured by Driada Medical for laboratory research applications. This compound, also known as Ostarine or Enobosarm, represents the most extensively studied SARM in preclinical and clinical research, with data from over 25 published studies involving more than 1,700 subjects according to manufacturer reports. At Stroid UK Shop, researchers investigating androgen receptor selectivity mechanisms can access this pharmaceutical-grade compound for comprehensive laboratory evaluations of tissue-selective androgenic activity.
Molecular Research Applications
Researchers studying MK2866 examine its unique mechanism as a non-steroidal SARM belonging to the aryl-propionamide class. This compound selectively modulates androgen receptors with demonstrated tissue selectivity in preclinical models, showing preferential binding to muscle and bone tissue over prostate tissue. The Ostarine research category encompasses investigations into cancer-related cachexia, stress urinary incontinence, and sarcopenia models. Scientific studies evaluate its oral bioavailability profile and dose-response relationships in various experimental frameworks, making it invaluable for researchers examining SARM compounds alongside complementary research into peptide mechanisms for comprehensive molecular pathway analysis.
Technical Specifications
| Parameter | Specification |
|---|---|
| Compound Name | MK-2866 (Ostarine/Enobosarm) |
| Molecular Formula | C₁₉H₁₄F₃N₃O₃ |
| Molecular Weight | 389.33 g/mol |
| CAS Number | 841205-47-8 |
| Classification | Non-steroidal SARM (aryl-propionamide) |
| Storage Conditions | Room temperature, dry environment |
| Manufacturer | Driada Medical |
| Research Applications | Androgen receptor selectivity studies |
Research Compliance Statement
MK2866 Driada Medical is exclusively manufactured and distributed for in-vitro laboratory research purposes only. This research chemical is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure compliance with all applicable institutional guidelines and regulatory frameworks when conducting studies with this compound. Proper laboratory safety protocols, including appropriate containment and disposal procedures, must be maintained throughout all experimental procedures. This product is restricted to qualified research institutions and licensed laboratories equipped for safe handling of research-grade chemical compounds.
